Cite

    C. Mathieu et al.. “Efficacy and safety of triple therapy with dapagliflozin add‐on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes.” Diabetes, obesity & metabolism, vol. 18, no. 11, 2016, pp. 1134–1137. http://access.bl.uk/ark:/81055/vdc_100038571264.0x00001f